Betulinic acid

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBetulinic acid
Drug Alias Name桦木酸ALS-357
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionDNA topoisomerase I inhibitorsCaspase stimulants
TargetsDNA topoisomerase ICaspase
Therapy Area/IndicationsDysplastic Nevus SyndromeMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDysplastic Nevus SyndromeMelanoma

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG